198 related articles for article (PubMed ID: 22918164)
21. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
Bachelez H
Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
[No Abstract] [Full Text] [Related]
22. CD4/CD8 double negative mycosis fungoides with PD-1 (CD279) expression--a disease of follicular helper T-cells?
Kempf W; Kazakov DV; Cipolat C; Kutzner H; Roncador G; Tomasini D
Am J Dermatopathol; 2012 Oct; 34(7):757-61. PubMed ID: 22722467
[TBL] [Abstract][Full Text] [Related]
23. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
24. IgG anti-50 kd lymphocyte membrane peptide antibody in patients with Sézary syndrome.
D'Ambra-Cabry K; Tharp MD; Jagasothy BV; Deng JS
J Am Acad Dermatol; 1996 May; 34(5 Pt 1):777-80. PubMed ID: 8632073
[TBL] [Abstract][Full Text] [Related]
25. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.
Rodríguez Pinilla SM; Roncador G; Rodríguez-Peralto JL; Mollejo M; García JF; Montes-Moreno S; Camacho FI; Ortiz P; Limeres-González MA; Torres A; Campo E; Navarro-Conde P; Piris MA
Am J Surg Pathol; 2009 Jan; 33(1):81-90. PubMed ID: 18987541
[TBL] [Abstract][Full Text] [Related]
27. Intertriginous mycosis fungoides: a distinct presentation of cutaneous T-cell lymphoma that may be caused by malignant follicular helper T cells.
Gammon B; Guitart J
Arch Dermatol; 2012 Sep; 148(9):1040-4. PubMed ID: 22986857
[TBL] [Abstract][Full Text] [Related]
28. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
29. Sézary syndrome and mycosis fungoides flow cytometric evaluation: The clinicians' perspective.
Guitart J
Cytometry B Clin Cytom; 2021 Mar; 100(2):129-131. PubMed ID: 32017375
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous T cell lymphoma differing from classical mycosis fungoides and Sézary syndrome: clinical, histological and immunohistochemical studies of six cases.
Maeda K; Takahashi M; Takatsuka N; Miyazawa H
J Dermatol; 1990 Apr; 17(4):226-34. PubMed ID: 2195088
[TBL] [Abstract][Full Text] [Related]
32. [Epidermotropic T lymphomas].
Sigal-Nahum M; Brousse N; Belaïch S
Rev Prat; 1987 May; 37(25):1423-31. PubMed ID: 3495856
[No Abstract] [Full Text] [Related]
33. Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome.
Martinez XU; Di Raimondo C; Abdulla FR; Zain J; Rosen ST; Querfeld C
Best Pract Res Clin Haematol; 2019 Sep; 32(3):239-252. PubMed ID: 31585624
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
Izban KF; Hsi ED; Alkan S
Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
[TBL] [Abstract][Full Text] [Related]
35. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
36. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome.
Dreno B; Celerier P; Fleischmann M; Bureau B; Litoux P
Acta Derm Venereol; 1994 Sep; 74(5):355-7. PubMed ID: 7817670
[TBL] [Abstract][Full Text] [Related]
37. Sézary syndrome: relative increase in T helper lymphocytes demonstrated by monoclonal antibodies.
Thivolet J; Fulton R; Souteyrand P; Gaucherand M; Claudy A
Acta Derm Venereol; 1982; 62(4):337-40. PubMed ID: 6183869
[No Abstract] [Full Text] [Related]
38. Immunophenotyping on simultaneously occurring plaques and tumours in mycosis fungoides and Sézary syndrome.
Preesman AH; Toonstra J; van der Putte SC; van Vloten WA
Br J Dermatol; 1993 Dec; 129(6):660-6. PubMed ID: 8286248
[TBL] [Abstract][Full Text] [Related]
39. Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides).
Gupta S; Safai B; Edelson R; Parrott D; Good R
Cell Immunol; 1980 Mar; 50(1):195-201. PubMed ID: 6967357
[No Abstract] [Full Text] [Related]
40. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
